HGH Fragment 176-191 5mg is a C-terminal growth hormone fragment supplied for preclinical research investigating selective GH lipolytic effects and metabolic regulation. This formulation supports controlled laboratory studies of growth hormone receptor signaling specificity and selective adipose tissue-targeted mechanisms.

Chemical Compound Information:

• Chemical Name: Growth hormone fragment 176-191 (GH C-terminal peptide)
• Molecular Formula: C₅₅H₈₇N₁₇O₁₆
• Molecular Weight: ~2,066 Da
• Compound Class: Peptide fragment; growth hormone receptor partial agonist

Description:
HGH Fragment 176-191 represents the C-terminal 16 amino acid sequence of native GH. The 5mg formulation enables systematic investigation of GH fragment-selective lipolytic properties and metabolic receptor signaling mechanisms in isolated adipocyte and tissue systems.

Research Applications:

• Investigation of fragment-specific growth hormone receptor activation patterns
• Study of lipolytic cascade activation in differentiated adipocyte cell lines
• Evaluation of GH fragment effects on hormone-sensitive lipase activity
• Assessment of selective fatty acid oxidation pathways in metabolic tissues
• Examination of fragment stability and receptor engagement kinetics in vitro

Storage and Handling:

• Store lyophilized powder at -20°C in sealed, light-protected containers
• Dissolve in sterile water or appropriate buffer solutions immediately before use
• Maintain working solutions at 2-8°C; use within 24-36 hours of preparation
• Protect from light exposure and freeze-thaw cycles during storage

Product Specifications:

• Purity: >98% by HPLC analysis
• Form: Lyophilized powder
• Quantity: 5mg per vial
• Appearance: White fine powder

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.